ImmunologybioRxiv
SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein.
S. Parn, K. Savsani, S. Dakshanamurthy
This study identifies CD8+ and CD4+ T cell epitopes specific to SARS-CoV-2 Omicron variants, targeting spike protein mutations, with high population coverage and potential for improved vaccine efficacy.
DOI 10.1016/j.immuno.2022.100020